Monday, May 30, 2016
How Wellcome and Gates charities profit from helping biotech
LONDON (Reuters) - The Wellcome Trust medical charity is to profit from U.S. approval of a new diagnostic cancer test, the first commercial product funded by the organization since the sale of its pharmaceuticals business to Glaxo in 1995.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment